{"id":"https://genegraph.clinicalgenome.org/r/78693f5e-e6d9-4a2b-995a-000cfbc0836dv1.0","type":"EvidenceStrengthAssertion","dc:description":"*CACNA1E* encodes the Î±1 E (Cav2.3) subunit of the high voltage-activated R-type calcium channel that initiates rapid synaptic transmission in the central nervous system. *CACNA1E* was first reported in relation to developmental and epileptic encephalopathy in 2018 (Helbig et al., PMID: 30343943). The main phenotypic features include severe to profound developmental impairment, often with non-verbal and non-ambulatory presentations, severe hypotonia, infantile-onset seizures, and spastic quadriplegia. More variable features include congenital joint contractures, hyperkinetic movement disorders, macrocephaly, developmental regression, autism spectrum disorder, and early death. Five recurrent and/or functionally validated *de novo* missense variants reported in 12 individuals are included in this curation (PMIDs: 30343943, 33776624). More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is gain of function (PMID: 30343943). *De novo* missense variants without functional evidence or truncating variants (PMIDs: 30343943, 34702355) were not scored. Additional evidence is needed to clarify the implication of these variants in this condition.\n\nIn summary, there is definitive evidence to support the relationship between *CACNA1E* and  autosomal dominant developmental and epileptic encephalopathy. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on December 6, 2023 (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/78693f5e-e6d9-4a2b-995a-000cfbc0836d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/0cf0db0a-4af2-4e60-ab64-ce0115241caf","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/0cf0db0a-4af2-4e60-ab64-ce0115241caf_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2024-03-14T02:47:15.658Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/0cf0db0a-4af2-4e60-ab64-ce0115241caf_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2023-12-06T20:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0cf0db0a-4af2-4e60-ab64-ce0115241caf_experimental_evidence_line","type":"EvidenceLine","specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0cf0db0a-4af2-4e60-ab64-ce0115241caf_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c9b34f3-62c3-4bb4-a11d-fb0b4ddabc4e","type":"EvidenceLine","dc:description":"LOF variants were not scored because the mechanism of disease is predicted to be different from that of functionally validated missense variants. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c9b34f3-62c3-4bb4-a11d-fb0b4ddabc4e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34702355","allele":{"id":"https://genegraph.clinicalgenome.org/r/72f03f2f-fbff-4c9f-89cf-14d4a31e6ecd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001205293.3(CACNA1E):c.3422+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343621795"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e24c9ce4-620c-45dd-b35e-af6172ace906","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e24c9ce4-620c-45dd-b35e-af6172ace906_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Phe698Ser transfected with alpha1e and beta2d subunits showed voltage dependence of activation was significantly shifted by -10 mV, and the time course of fast inactivation was significantly slowed for this variant compared to wild-type. These results indicate this variant altered both channel activation and inactivation. This variant increased residual current density but whole cell current density was not shown to be significantly different than wild-type.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e24c9ce4-620c-45dd-b35e-af6172ace906_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/786a40f0-83c8-4ff2-8c0b-fc1cafaa91c1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001205293.3(CACNA1E):c.2094C>A (p.Phe698Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343628381"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ac1601a8-3cee-4b8e-a1a3-9afbf6485aab","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac1601a8-3cee-4b8e-a1a3-9afbf6485aab_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"See Helbig Individual 19","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ac1601a8-3cee-4b8e-a1a3-9afbf6485aab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/9d563bd8-002f-4035-a8df-20bcb51b2544","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001205293.3(CACNA1E):c.2104G>A (p.Ala702Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA33822752"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/969c3527-dc7c-467a-89c8-66d3ce708058","type":"EvidenceLine","dc:description":"Missense variant with no functional evidence of pathogenicity.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/969c3527-dc7c-467a-89c8-66d3ce708058_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34702355","allele":{"id":"https://genegraph.clinicalgenome.org/r/d218bbb5-cfb6-4c82-8fbe-b81f0987b2b4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001205293.3(CACNA1E):c.2105C>T (p.Ala702Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343628405"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/31f9af6a-0c38-4342-a991-c55ab0725529","type":"EvidenceLine","dc:description":"LOF variants were not scored because the mechanism of disease is predicted to be different from that of functionally validated missense variants. This patient is a somatic mosaic with a mutant allele fraction of 27% in peripheral blood leukocytes (6/22 reads).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31f9af6a-0c38-4342-a991-c55ab0725529_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/7080c39f-c645-40b4-927b-0300c05e800f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001205293.3(CACNA1E):c.2485C>T (p.Arg829Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343617450"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ce9d8188-c515-4f22-9540-e24cc1f7c945","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce9d8188-c515-4f22-9540-e24cc1f7c945_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"See Helbig Individual 16","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ce9d8188-c515-4f22-9540-e24cc1f7c945_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/02939c8f-8ebc-468e-8ed3-62797ede2f1b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001205293.3(CACNA1E):c.2101A>G (p.Ile701Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343628397"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e81f3cc1-fb42-4dd2-8f61-1f0e62564d6f","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e81f3cc1-fb42-4dd2-8f61-1f0e62564d6f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"See Helbig Individual 16","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e81f3cc1-fb42-4dd2-8f61-1f0e62564d6f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/02939c8f-8ebc-468e-8ed3-62797ede2f1b"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/deb44a92-c141-481f-9193-6dbc9ca70eba","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/deb44a92-c141-481f-9193-6dbc9ca70eba_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"See Helbig Individual 3","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/deb44a92-c141-481f-9193-6dbc9ca70eba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/2e095010-b619-46c7-8d6d-11ddd84c7c84","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001205293.3(CACNA1E):c.1054G>A (p.Gly352Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10588271"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8d9770a4-def6-4527-9276-83dbba05f8b7","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d9770a4-def6-4527-9276-83dbba05f8b7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"See Helbig Individual 3","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8d9770a4-def6-4527-9276-83dbba05f8b7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/2e095010-b619-46c7-8d6d-11ddd84c7c84"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/cab24b0a-0c10-4d9f-8b8f-36120a3c1579","type":"EvidenceLine","dc:description":"Missense variant with no functional evidence of pathogenicity.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cab24b0a-0c10-4d9f-8b8f-36120a3c1579_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/590e9400-bd2a-4280-8e51-032223e7de95","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001205293.3(CACNA1E):c.4274C>A (p.Thr1425Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343624475"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/07d52c6d-98ea-419a-a722-02591e920552","type":"EvidenceLine","dc:description":"LOF variants were not scored because the mechanism of disease is predicted to be different from that of functionally validated missense variants. Additionally, this variant is paternally inherited. Father of the proband has mild learning disability, possible seizures beginning at 42y (EEG normal).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/07d52c6d-98ea-419a-a722-02591e920552_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/f7c08687-8f10-4c85-9228-23c064731efa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001205293.3(CACNA1E):c.4263_4271delinsG (p.Ile1422HisfsTer8)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2586967743"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d49d06be-8622-4b31-9f3a-257b2de29466","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d49d06be-8622-4b31-9f3a-257b2de29466_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Whole cell current traces of Xenopus oocytes expressing Gly352Arg demonstrated the variant significantly slowed channel inactivation compared to the CaV2.3 wild-type channel. Ratio of whole cell current remaining at the end of a 300-ms pulse also showed it was significantly higher for the Gly352Arg variant compared to wild-type. Additionally, the voltage dependence of activation and inactivation were significantly different in G352R compared to wild-type with a -15-mV shift in the activation potential, together with a +12-mV shift in the voltage dependence of inactivation. This suggests that G352R stabilizes the open state of CaV2.3 by a gain-of-function mechanism of disease.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d49d06be-8622-4b31-9f3a-257b2de29466_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/2e095010-b619-46c7-8d6d-11ddd84c7c84"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/afff1778-2aed-486a-99d0-e4e6c3ce1171","type":"EvidenceLine","dc:description":"LOF variants were not scored because the mechanism of disease is predicted to be different from that of functionally validated missense variants. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/afff1778-2aed-486a-99d0-e4e6c3ce1171_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/bbdd8dec-29bf-45d0-98c0-8d0acaa16b49","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001205293.3(CACNA1E):c.4165C>T (p.Arg1389Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343624227"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/2cbacd1c-e3c1-491b-a93f-bc9e21c2f8fa","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cbacd1c-e3c1-491b-a93f-bc9e21c2f8fa_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"See Helbig Individual 3","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2cbacd1c-e3c1-491b-a93f-bc9e21c2f8fa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33776624","allele":{"id":"https://genegraph.clinicalgenome.org/r/2e095010-b619-46c7-8d6d-11ddd84c7c84"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b82593c4-715e-47cf-9629-265a9ee444d2","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b82593c4-715e-47cf-9629-265a9ee444d2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"See Helbig Individual 19","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b82593c4-715e-47cf-9629-265a9ee444d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/9d563bd8-002f-4035-a8df-20bcb51b2544"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/79e4a52e-3d96-4f0a-b5c3-e5696b9f3df1","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79e4a52e-3d96-4f0a-b5c3-e5696b9f3df1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Ala702Thr transfected with alpha1e and beta2d subunits showed voltage dependence of activation was significantly shifted by -10 mV, and that time course of fast inactivation was significantly slowed for this variant compared to wild-type. These results indicate this variant altered both channel activation and inactivation. This variant increased residual current density but whole cell current density was not shown to be significantly different than wild-type.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/79e4a52e-3d96-4f0a-b5c3-e5696b9f3df1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/9d563bd8-002f-4035-a8df-20bcb51b2544"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e67e7aec-ec2f-4fc2-87fc-601bba589c3b","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e67e7aec-ec2f-4fc2-87fc-601bba589c3b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Ile701Val transfected with alpha1e and beta2d subunits showed voltage dependence of activation was significantly shifted by -10 mV, and that time course of fast inactivation was significantly slowed for this variant compared to wild-type. These results indicate this variant altered both channel activation and inactivation. This variant increased residual current density but whole cell current density was not shown to be significantly different than wild-type.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e67e7aec-ec2f-4fc2-87fc-601bba589c3b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/02939c8f-8ebc-468e-8ed3-62797ede2f1b"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/298d9b16-c974-4036-b2eb-26bad35dd3a4","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/298d9b16-c974-4036-b2eb-26bad35dd3a4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"See Helbig Individual 3","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/298d9b16-c974-4036-b2eb-26bad35dd3a4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/2e095010-b619-46c7-8d6d-11ddd84c7c84"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b3aa4b5e-6174-4da4-a978-7c0a591c26b3","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b3aa4b5e-6174-4da4-a978-7c0a591c26b3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"p.Ile603Leu co-expressed with beta1b and alpha2delta1 subunits in tsA201 cells resulted in a significant increase in whole-cell current density and >10 mV hyperpolarizing shift in half activation voltage. This variant did not have any significant effect on channel inactivation. This data supports a gain-of-function mechanism of disease.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b3aa4b5e-6174-4da4-a978-7c0a591c26b3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/406ea317-2bdb-4e21-a33b-095fe2df1809","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001205293.3(CACNA1E):c.1807A>C (p.Ile603Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16603493"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/368729f2-b7b2-4ecb-b482-52c9c136cbc8","type":"EvidenceLine","dc:description":"Missense variant with no functional evidence of pathogenicity.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/368729f2-b7b2-4ecb-b482-52c9c136cbc8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343943","allele":{"id":"https://genegraph.clinicalgenome.org/r/590e9400-bd2a-4280-8e51-032223e7de95"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":7897,"specifiedBy":"GeneValidityCriteria10","strengthScore":12,"subject":{"id":"https://genegraph.clinicalgenome.org/r/z2c158yK5u4","type":"GeneValidityProposition","disease":"obo:MONDO_0100062","gene":"hgnc:1392","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_0cf0db0a-4af2-4e60-ab64-ce0115241caf-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}